20012023

Research activity per year

Personal profile

specialisation

quality of life, lung cancer, PROMS, personalised medicine, PET-CT

Research interests

The quality of life and survival of patients with (advanced) lung cancer remain poor despite promising new treatments. In my current, almost finished, prospective randomised controlled trial (SYMPRO-study) try to determine whether symptom monitoring with PRO measurement using a web-application improves Health related quality of life (HRQL), OS and health service outcomes among lung cancer patients in the Netherlands. First results show this is a positive trial.

My second trial financed by ZorgInstituutNederland (Veelbelovende Zorg) is in cooperation with Radboud UMC. Hardly any international evidence exist on how to follow-up patients after curative treatment in locally advanced lung cancer. The hypothesis of this study is that 18F FDG PET scan - in addition to the usual CT scan- improves early detection of recurrences and thereby increases earlier treatment, health-related quality of life and overall survival. A multicenter randomised controlled trial will start in July 2023 and is endorsed by the NVALT.  

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or